According to the Angelman Syndrome Foundation, an estimated 1 in 15,000 people are born with Angelman Syndrome, making it a rare genetic disorder. It is estimated that there are currently between 7,000 and 10,000 individuals living with Angelman Syndrome in the United States and between 50,000 and 75,000 people living with the condition worldwide. Due to the wide range of severity and range of symptoms, it is difficult to accurately estimate the exact number of people with Angelman Syndrome globally.
In terms of demographics, Angelman Syndrome is more common in males than females. It is most commonly diagnosed in infancy or early childhood. The condition is found in all races, ethnicities, and socio-economic groups, although rates may vary by population.
There is currently no cure for Angelman Syndrome, though there are treatments and therapies available that can help manage symptoms and improve quality of life. With early intervention and ongoing support, individuals with Angelman Syndrome can lead full and meaningful lives.